Evaluation of the efficacy of Xeomin in the treatment of cervical dystonia (CD) and blepharospasmus (BS) in patients who did not respond to treatment with Botox.
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Blepharospasm; Torticollis
- Focus Therapeutic Use
- 03 Aug 2012 New trial record